Skip to main content

HighTower Advisors, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1462245 CHICAGO, IL

Position in NBIX

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$1,475,224
-$265,171 QoQ
Shares Held
11,198
-8.7% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

HighTower Advisors, LLC holds $76,791,783 across 32 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 NBIX
Neurocrine Biosciences Inc
This page
11,198 $1,475,224

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,475,224 11,198
2025-12-31 $1,740,395 12,271
2025-09-30 $1,326,450 9,449
2025-06-30 $1,214,542 9,663
2025-03-31 $1,071,050 9,684
2024-12-31 $1,446,900 10,600
2024-09-30 $1,104,614 9,587
2024-06-30 $4,043,643 29,372
2024-03-31 $2,198,168 15,938
2023-12-31 $2,026,732 15,382
2023-09-30 $813,712 7,233
2023-06-30 $623,134 6,608
2023-03-31 $800,144 7,905
2022-12-31 $989,679 8,286
2022-09-30 $609,220 5,736
2022-06-30 $564,701 5,793
2022-03-31 $538,593 5,745
2021-12-31 $328,926 3,862
2021-09-30 $575,843 6,004
2021-06-30 $3,148,107 32,348
2021-03-31 $577,859 5,942
2020-12-31 $548,070 5,718
2020-09-30 $786,877 8,183
2020-06-30 $555,344 4,552
2020-03-31 $405,313 4,683